Daratumumab combined with standard treatment for multiple myeloma produced deep and durable responses in relapsed or refractory patients
- Details
- Category: Johnson & Johnson

GSK receives European marketing authorisation for Nucala® (mepolizumab) in 31 countries
- Details
- Category: GlaxoSmithKline

Roche and Upsher-Smith announce license agreement to develop novel VAP-1 inhibitor
- Details
- Category: Roche

Bristol-Myers Squibb Foundation marks World AIDS Day with grants totaling more than $3.5M
- Details
- Category: Bristol-Myers Squibb

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)
- Details
- Category: Boehringer Ingelheim

Roche receives EU approval of Cotellic for use in combination with Zelboraf in advanced melanoma
- Details
- Category: Roche

AstraZeneca enters into agreement with Perrigo for rights to Entocort® in the US
- Details
- Category: AstraZeneca

More Pharma News ...
- Bayer's new five-year-contraceptive submitted for EU and US marketing authorization
- Merck and Pfizer receive FDA Breakthrough Therapy designation for avelumab in metastatic Merkel cell carcinoma
- Roche to restructure its manufacturing network for small molecules
- Global partners announce donation of 500 millionth dose of azithromycin
- International study prompts rethink on the rise of diabetes in cities
- Boehringer Ingelheim will invest 11 billion euros in Research and Development in the next five years
- Boehringer Ingelheim partners with leading scientific institutions in inflammatory bowel disease research